<?xml version="1.0" encoding="utf-8" standalone="no"?>
<billStatus>
  <version>3.0.0</version>
  <bill>
    <number>569</number>
    <updateDate>2023-01-11T19:58:15Z</updateDate>
    <updateDateIncludingText>2023-01-11T19:58:15Z</updateDateIncludingText>
    <originChamber>Senate</originChamber>
    <originChamberCode>S</originChamberCode>
    <type>S</type>
    <introducedDate>2007-02-13</introducedDate>
    <congress>110</congress>
    <committees>
      <item>
        <systemCode>ssfr00</systemCode>
        <name>Foreign Relations Committee</name>
        <chamber>Senate</chamber>
        <type>Standing</type>
        <activities>
          <item>
            <name>Referred to</name>
            <date>2007-02-13T20:45:08Z</date>
          </item>
        </activities>
      </item>
    </committees>
    <relatedBills>
      <item>
        <title>Vaccines for the Future Act of 2007</title>
        <congress>110</congress>
        <number>1391</number>
        <type>HR</type>
        <latestAction>
          <actionDate>2007-04-13</actionDate>
          <text>Referred to the Subcommittee on Domestic and International Monetary Policy, Trade, and Technology.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Identical bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
    </relatedBills>
    <actions>
      <item>
        <actionDate>2007-02-13</actionDate>
        <committees>
          <item>
            <systemCode>ssfr00</systemCode>
            <name>Foreign Relations Committee</name>
          </item>
        </committees>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Read twice and referred to the Committee on Foreign Relations. (text of measure as introduced: CR S1912-1913)</text>
        <type>IntroReferral</type>
      </item>
      <item>
        <actionDate>2007-02-13</actionDate>
        <text>Sponsor introductory remarks on measure. (CR S1912)</text>
        <type>IntroReferral</type>
        <actionCode>B00100</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2007-02-13</actionDate>
        <text>Introduced in Senate</text>
        <type>IntroReferral</type>
        <actionCode>10000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
    </actions>
    <sponsors>
      <item>
        <bioguideId>L000504</bioguideId>
        <fullName>Sen. Lugar, Richard G. [R-IN]</fullName>
        <firstName>RICHARD</firstName>
        <lastName>LUGAR</lastName>
        <party>R</party>
        <state>IN</state>
        <middleName>GREEN</middleName>
        <isByRequest>N</isByRequest>
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>I000025</bioguideId>
        <fullName>Sen. Inouye, Daniel K. [D-HI]</fullName>
        <firstName>DANIEL</firstName>
        <lastName>INOUYE</lastName>
        <party>D</party>
        <state>HI</state>
        <middleName>KEN</middleName>
        <sponsorshipDate>2007-05-24</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
    </cosponsors>
    <policyArea>
      <name>International Affairs</name>
    </policyArea>
    <subjects>
      <legislativeSubjects>
        <item>
          <name>AIDS (Disease)</name>
        </item>
        <item>
          <name>Child health</name>
        </item>
        <item>
          <name>Commerce</name>
        </item>
        <item>
          <name>Communicable diseases</name>
        </item>
        <item>
          <name>Competition</name>
        </item>
        <item>
          <name>Congress</name>
        </item>
        <item>
          <name>Congressional reporting requirements</name>
        </item>
        <item>
          <name>Developing countries</name>
        </item>
        <item>
          <name>Development credit institutions</name>
        </item>
        <item>
          <name>Drug approvals</name>
        </item>
        <item>
          <name>Drug industry</name>
        </item>
        <item>
          <name>Epidemics</name>
        </item>
        <item>
          <name>Families</name>
        </item>
        <item>
          <name>Foreign Trade and International Finance</name>
        </item>
        <item>
          <name>Foreign investments</name>
        </item>
        <item>
          <name>Government Operations and Politics</name>
        </item>
        <item>
          <name>Health</name>
        </item>
        <item>
          <name>Health planning</name>
        </item>
        <item>
          <name>Human immunodeficiency viruses</name>
        </item>
        <item>
          <name>Infant mortality</name>
        </item>
        <item>
          <name>Infants</name>
        </item>
        <item>
          <name>Intellectual property</name>
        </item>
        <item>
          <name>Malaria</name>
        </item>
        <item>
          <name>Mortality</name>
        </item>
        <item>
          <name>Negotiations</name>
        </item>
        <item>
          <name>Orphan drugs</name>
        </item>
        <item>
          <name>Pharmaceutical research</name>
        </item>
        <item>
          <name>Pneumonia</name>
        </item>
        <item>
          <name>Preventive medicine</name>
        </item>
        <item>
          <name>Public-private partnerships</name>
        </item>
        <item>
          <name>Science, Technology, Communications</name>
        </item>
        <item>
          <name>Tuberculosis</name>
        </item>
        <item>
          <name>Vaccines</name>
        </item>
        <item>
          <name>World health</name>
        </item>
      </legislativeSubjects>
      <policyArea>
        <name>International Affairs</name>
      </policyArea>
    </subjects>
    <summaries>
      <summary>
        <versionCode>00</versionCode>
        <actionDate>2007-02-13</actionDate>
        <actionDesc>Introduced in Senate</actionDesc>
        <updateDate>2007-03-06T19:58:41Z</updateDate>
        <text><![CDATA[ <p>Vaccines for the Future Act of 2007 - Directs the President to establish a comprehensive strategy to accelerate efforts to develop vaccines and microbicides for neglected diseases such as HIV/AIDS, malaria, and tuberculosis.</p> <p>States that such strategy shall: (1) expand public-private partnerships and seek to leverage foreign country and private sector resources; (2) include the negotiation of advance market commitments and other economic incentives for the research, development, and manufacturing of vaccines and microbicides for HIV/AIDS, tuberculosis, malaria, and other neglected diseases; (3) address related intellectual property and regulatory issues; (4) maximize U.S. capabilities to support clinical trials of vaccines and microbicides in developing countries; and (5) expand the purchase and delivery of existing vaccines. </p> <p>Directs the Secretary of the Treasury to enter into negotiations with the World Bank, the International Development Association, the GAVI Alliance, such entities' member nations, and other interested parties to establish advance market commitments to purchase vaccines and microbicides to combat neglected diseases. (Defines &quot;GAVI Alliance&quot; as the public-private partnership launched in 2000 for the purpose of saving children and protecting all people through the widespread use of vaccines.)</p>]]></text>
      </summary>
    </summaries>
    <title>Vaccines for the Future Act of 2007</title>
    <titles>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <title>A bill to accelerate efforts to develop vaccines for diseases primarily affecting developing countries and for other purposes.</title>
        <billTextVersionName>Introduced in Senate</billTextVersionName>
        <billTextVersionCode>IS</billTextVersionCode>
      </item>
      <item>
        <titleType>Display Title</titleType>
        <title>Vaccines for the Future Act of 2007</title>
      </item>
      <item>
        <titleType>Short Titles as Introduced</titleType>
        <title>Vaccines for the Future Act of 2007</title>
      </item>
    </titles>
    <textVersions>
      <item>
        <type>Introduced in Senate</type>
        <date>2007-02-13T05:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-110s569is/xml/BILLS-110s569is.xml</url>
          </item>
        </formats>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2007-02-13</actionDate>
      <text>Read twice and referred to the Committee on Foreign Relations. (text of measure as introduced: CR S1912-1913)</text>
    </latestAction>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>
